EUVIMEDEUVIMED entdecken
Crossref

Naringin activates semaphorin 3A to ameliorate TGF‐β‐induced endothelial‐to‐mesenchymal transition related to atrial fibrillation

Ying-Ju Lai iD, Shang-Hung Chang, Ying-Chang Tung, Gwo-Jyh Chang, Celina De Almeida, Wei-Jan Chen, Yung-Hsin Yeh iD, Feng-Chun Tsai

Journal of Cellular Physiology · 2024

DOI: 10.1002/jcp.31248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2024. Verfasst von Ying-Ju Lai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Department, Chang-Gung Memorial Hospital, Tao-Yuan, Taiwan. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cell Proliferation, Endothelial Cells, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan, Chang Gung Medical Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The loss of semaphorin 3A (Sema3A), which is related to endothelial‐to‐mesenchymal transition (EndMT) in atrial fibrosis, is implicated in the pathogenesis of atrial fibrillation (AF). To explore the mechanisms by which EndMT affects atrial fibrosis and assess the potential of a Sema3A activator (naringin) to prevent atrial fibrosis by targeting transforming growth factor‐beta (TGF‐β)‐induced EndMT, we used human atria, isolated human atrial endocardial endothelial cells (AEECs), and used transgenic mice expressing TGF‐β specifically in cardiac tissues (TGF‐β transgenic mice). We evaluated an EndMT marker (Twist), a proliferation marker (proliferating cell nuclear antigen; PCNA), and an endothelial cell (EC) marker (CD31) through triple immunohistochemistry and confirmed that both EndMT and EC proliferation contribute to atrial endocardial fibrosis during AF in TGF‐β transgenic mice and AF patient tissue sections. Additionally, we investigated the impact of naringin on EndMT and EC proliferation in AEECs and atrial fibroblasts. Naringin exhibited an antiproliferative effect, to which AEECs were more responsive. Subsequently, we downregulated Sema3A in AEECs using small interfering RNA to clarify a correlation between the reduction in Sema3A and the elevation of EndMT markers. Naringin treatment induced the expression of Sema3A and a concurrent decrease in EndMT markers. Furthermore, naringin administration ameliorated AF and endocardial fibrosis in TGF‐β transgenic mice by stimulating Sema3A expression, inhibiting EndMT markers, reducing atrial fibrosis, and lowering AF vulnerability. This suggests therapeutic potential for naringin in AF treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCell ProliferationEndothelial CellsEpithelial-Mesenchymal TransitionFlavanonesHeart AtriaSemaphorin-3ATransforming Growth Factor betaAnimalsHumansMaleMiceCells, CulturedFibroblastsFibrosisMice, Transgenic

Stichwörter der Autor:innen

atrial endocardial endothelial cellsatrial fibrosisendothelial‐to‐mesenchymal transitionnaringinsemaphorin 3A

Substanzen

FlavanonesSemaphorin-3ATransforming Growth Factor betanaringin

Autor:innen und Institutionen

  • Cardiovascular Department, Chang-Gung Memorial Hospital, Tao-Yuan, Taiwan.
  • Department of Respiratory Therapy, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan.
  • Department of Respiratory Care, Chang-Gung University of Science and Technology, Chia-Yi, Puzi, Taiwan.
  • Department of Medicine, College of Medicine, Chang Gung University Tao-Yuan, Tao-Yuan, Taiwan.
  • Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang-Gung University Tao-Yuan, Tao-Yuan, Taiwan.
  • Department of Surgery, Division of Cardiovascular Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

ORCID-Profile: Ying-Ju Lai, Yung-Hsin Yeh

Förderung

  • Ministry of Science and Technology, Taiwan
  • Chang Gung Medical Research Program

Zitieren

APA

Lai, Y. J., Chang, S. H., Tung, Y. C., Chang, G. J., Almeida, C., Chen, W. J., Yeh, Y. H., & Tsai, F. C. (2024). Naringin activates semaphorin 3A to ameliorate TGF‐β‐induced endothelial‐to‐mesenchymal transition related to atrial fibrillation. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31248

Vancouver

Lai YJ, Chang SH, Tung YC, Chang GJ, Almeida C, Chen WJ, et al. Naringin activates semaphorin 3A to ameliorate TGF‐β‐induced endothelial‐to‐mesenchymal transition related to atrial fibrillation. Journal of Cellular Physiology. 2024. doi:10.1002/jcp.31248

BibTeX
@article{Lai2024,
  author = {Lai, Ying-Ju and Chang, Shang-Hung and Tung, Ying-Chang and Chang, Gwo-Jyh and Almeida, Celina De and Chen, Wei-Jan and Yeh, Yung-Hsin and Tsai, Feng-Chun},
  title = {Naringin activates semaphorin 3A to ameliorate TGF‐β‐induced endothelial‐to‐mesenchymal transition related to atrial fibrillation},
  journal = {Journal of Cellular Physiology},
  year = {2024},
  doi = {10.1002/jcp.31248}
}
Kostenlos starten →